CytoCore Inc.
Description Cytocore, Inc. develops, manufactures, and sells an integrated family of products for the detection, diagnosis, and treatment of cancer under the CytoCore Solutions trade name. The companys CytoCore Solutions products focus on addressing sample collection; specimen preparation; specimen evaluation, including detection/screening, and diagnosis; and treatment and patient monitoring related to specific cancers. Its cell collection devices include SoftPAP, a device for the collection of cervical cell samples that are used in the detection of cervical dysplasia, cancer, and human papillomavirus infections; and PadKit, a sample collection device that ensures female reproductive tract health. The company is also developing stains and reagents for use in cervical cytology and other screening applications, as well as cell preservatives for cytological applications. In addition, it focuses on developing specimen evaluation products, such as AIPS workstation to address the root causes of various ergonomic problems; and AIPS Imager, a medical screening program to differentiate between patients who show no evidence of the target disease state and those who do, as well as developing a derivative of the SoftPAP cell collection device to apply a patch containing a therapeutic agent to the cervix. The company was formerly known as Molecular Diagnostics, Inc. and changed its name to Cytocore, Inc. in June 2006. Cytocore, Inc. is based in Chicago, Illinois. To view the detailed information, you need to SUBSCRIBE with us. |
 |